Adamas Pharmaceuticals Inc (23) | Human Resources (10)

Browse by Subcategory

Recent Contracts

Form of Performance Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on May 10, 2021)
Compensation arrangements with Executive Officers (Filed With SEC on February 23, 2021)
Adamas Pharmaceuticals, Inc. Amended and Restated Executive Severance Plan (Filed With SEC on February 23, 2021)
Extension to Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated July 15, 2020 (Filed With SEC on November 5, 2020)
Employment Offer by and between Adamas Pharmaceuticals, Inc. and Neil F. McFarlane, dated September 12, 2019 (Filed With SEC on November 7, 2019)
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Jennifer Rhodes, dated January 9, 2020 (Filed With SEC on May 7, 2020)
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated February 25, 2020 (Filed With SEC on May 7, 2020)
2020 Compensation actions with respect to Non-Employee Directors (Filed With SEC on May 7, 2020)
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Alfred G. Merriweather, dated August 7, 2019 (Filed With SEC on November 7, 2019)
Transition, separation, and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Gregory T. Went, Ph.D., dated September 11, 2019 (Filed With SEC on November 7, 2019)